Clinical Trials
- Liver Cancer
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
- Liver Cancer
A Phase Ib/II, Open-Label, Multicenter, Randomized Platform Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma (MORPHEUS-NEO HCC)